Hepatocyte growth factor promotes lymphatic vessel formation and function. - Wikidata - wikimedia - TriplyDB

Hepatocyte growth factor promotes lymphatic vessel formation and function.

Hepatocyte growth factor promotes lymphatic vessel formation and function.

http://www.wikidata.org/entity/Q33919993

about

Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells Lymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axis Broad targeting of angiogenesis for cancer prevention and therapy Lymphatic vascular response to acute inflammation Evidence for SH2 domain-containing 5'-inositol phosphatase-2 (SHIP2) contributing to a lymphatic dysfunction Genetics of lymphatic anomalies Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.Mechanoinduction of lymph vessel expansion.Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas Tumour vascularization: sprouting angiogenesis and beyond Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.Expression of MACC1 and c-Met in human gastric cancer and its clinical significance.Molecular mechanisms of resistance to tumour anti-angiogenic strategies Neuronal and nonneuronal cholinergic structures in the mouse gastrointestinal tract and spleen Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.Netrin-4 induces lymphangiogenesis in vivo The lymphatic system in health and disease.Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin.Targeting lymphatic vessel functions through tyrosine kinases.Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration.The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis HGF and MET mutations in primary and secondary lymphedema Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis.The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.Lymphangiogenesis and hemangiogenesis: potential targets for therapy Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function.VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis Apelin attenuates UVB-induced edema and inflammation by promoting vessel function Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis The Naïve Murine Cornea as a Model System to Identify Novel Endogenous Regulators of Lymphangiogenesis: TRAIL and rtPA.Tumor lymphangiogenesis as a potential therapeutic target.Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium.Lymphatic-specific expression of dipeptidyl peptidase IV and its dual role in lymphatic endothelial function Lymphangiogenesis and cancer Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.

P2860

Q24318473-490BFB33-27AA-4584-8A30-A374573B97CC Q26825144-03DC8C57-30EA-4C81-95EB-64044384C4BF Q27002903-D6F843DB-FCA0-4859-BEA5-40A8259F5164 Q27304915-15A3747D-FA45-4DA6-870D-023B3E42EBFC Q27329602-04DED56B-C5E3-4B31-9D09-04C25CFB96B0 Q28308201-1793CCED-4F40-4BF8-AF57-F128E18C1701 Q30479201-9864F59E-84D7-43BC-8C90-81599218D406 Q30505376-0AC495F6-3048-415B-9D23-18954A4824B8 Q33288480-5658FBFD-A76F-413D-BE7C-6820FB36EA97 Q33556162-09439102-4242-4558-8017-54CC9DC2BEE6 Q33616451-0BA7A86D-BB65-4290-ADFF-FC8837BE82D7 Q33643400-175F5794-73FE-452E-9C40-2713BFC3CBDC Q33718025-3E80D4E0-62D9-4670-AE7A-CE7F91320E5E Q33844467-61823727-E52E-4BD4-8E11-50FD91716B63 Q33905052-1B604815-E10E-4005-9E8D-8F5BA3956332 Q33985154-DAEFFB6D-C1A0-4BA2-815A-1A745E4F3A48 Q34015299-24304B30-C141-4A65-B9F5-BACDDE98EC61 Q34033409-72404377-BC5E-4C19-A1F7-2E749D578B2D Q34078275-75B2C36F-D07D-487C-A0BF-F98FF27203C9 Q34199527-E8DF9D83-630F-44AA-AFA3-1C4B29A75804 Q34482531-43CED31A-D4CD-4134-8B93-EF3112E54AAD Q34488846-A645B720-D567-425C-8417-902C26CEE261 Q34560457-AFBE0A8E-0537-42BE-A46E-38BDB2FEF214 Q34983851-ECF01F1B-186E-4505-808E-9B4C1C6763AA Q35060325-9CBD3056-227D-417F-9C18-B42B3025C6A8 Q35563524-14499A9B-FB3B-42E8-97D6-D7C5FAB69C8D Q35574091-6159603B-973D-4A53-9D0E-8AA3D670625A Q35575870-7FC53699-1465-43ED-9F85-0E77413A60B4 Q35607278-A9965580-4C09-4396-922A-653DE241AFAC Q35616124-0D5063E2-F0A1-4B87-80B1-9F6C7362E2E0 Q35618825-33AC557F-CA38-4343-8E70-61AA084807B8 Q35679447-335C5D16-EA03-41DD-9432-CB25D4CA09EA Q35810928-D4D81601-D9A5-4BF2-B03C-0A7C281D59FA Q35822076-B35A4BCD-4666-407F-9149-4180283CFB8F Q35838122-2E732870-0720-4B42-A13E-579C0F14EF6A Q35882208-A89F645D-19C1-4A8B-A6D2-04E811F29F88 Q36098596-59418876-D879-4106-83C8-C26F3E4142A7 Q36098601-74B59235-C77B-4DEE-A799-0045FB753D36 Q36137692-6B464C30-A4B3-449F-A78B-B0D962603D26 Q36198192-A4647AD2-5237-457C-A153-E82A5EA0FA88

P2860

Hepatocyte growth factor promotes lymphatic vessel formation and function.

http://www.wikidata.org/entity/Q33919993

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Hepatocyte growth factor promotes lymphatic vessel formation and function.

@ast

Hepatocyte growth factor promotes lymphatic vessel formation and function.

@en

type

label

Hepatocyte growth factor promotes lymphatic vessel formation and function.

@ast

Hepatocyte growth factor promotes lymphatic vessel formation and function.

@en

prefLabel

Hepatocyte growth factor promotes lymphatic vessel formation and function.

@ast

Hepatocyte growth factor promotes lymphatic vessel formation and function.

@en

P1433

Q33919993-BA0BED68-F7C2-4A45-AD1C-BE2E7530F683

P1476

Q33919993-363C133F-21A2-4A06-8BF7-972D659E4FF8

P2093

Q33919993-573FD008-F81B-4072-B5A0-2BC926E38770

Q33919993-83A37869-AEEA-4D63-BBCC-9B598F6C9BFE

Q33919993-D4B16242-BEC6-4280-A955-3D3AEC7E2F75

Q33919993-EDC5C035-AE40-49BA-8BF4-187BD72055B5

P2860

Q33919993-009D59DA-4ABF-4C8F-BE67-F1417E4FD7E1

Q33919993-0816BEA6-CCBB-46A5-BB5C-B66C31244278

Q33919993-0CC40426-B71B-4466-B780-DE449FAC4106

Q33919993-0ED20F7C-19DF-441A-8CCC-377583570F18

Q33919993-13BF62DE-7576-4193-8588-38852FE37C51

Q33919993-153B43C5-3D22-4D24-B0F7-27C2F969BADD

Q33919993-23F805C2-5DBC-4C38-95E9-958D4C634026

Q33919993-24981E7B-1347-45D9-B889-8C6E69CD01E0

Q33919993-28B1A472-7506-4027-A16D-F4A7DA171F75

Q33919993-31309CF6-2464-413B-94D5-C94FCF8CAC54

P304

Q33919993-7EB4C764-23E0-4583-8A3F-DFFAA60FA66D

P31

Q33919993-AEE1BC9C-A6B8-4183-95A9-ED68DE74F69D

P356

Q33919993-159CDB58-90E4-418D-A582-E93EB1176FE0

P407

Q33919993-8D6555AF-70CB-457A-9A35-939BC9A282C3

P433

Q33919993-ED5C9622-13E4-4819-8BBD-20D6FFE60FCA

P478

Q33919993-ADAEB009-02AD-46FF-B4FF-8E93EE773387

P50

Q33919993-605A074F-6D44-4EBA-AF9B-24966302CE0D

P577

Q33919993-5788C344-BEE7-4189-8BF8-53122F2E2CFB

P5875

Q33919993-3914338A-4422-4F63-A51B-F557E19BF74D

P698

Q33919993-CA8AA8BC-F3D9-4A9E-8A90-345B47B53AD2

P932

Q33919993-5929ACB7-2EF4-48BC-B54B-C7F205314C8A

P356

SJ.EMBOJ.7600763

P1433

The EMBO Journal

P1476

Hepatocyte growth factor promotes lymphatic vessel formation and function.

@en

P2093

Beijia Ma

http://www.w3.org/2001/XMLSchema#string

Ines Drinnenberg

http://www.w3.org/2001/XMLSchema#string

Kentaro Kajiya

http://www.w3.org/2001/XMLSchema#string

Satoshi Hirakawa

http://www.w3.org/2001/XMLSchema#string

P2860

Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor

Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor

Molecular cloning and expression of human hepatocyte growth factor

Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins

The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.

Met, metastasis, motility and more

An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype

P304

2885-2895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.EMBOJ.7600763

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7693996

http://www.w3.org/2001/XMLSchema#string

P698

16052207

http://www.w3.org/2001/XMLSchema#string

P932

1187946

http://www.w3.org/2001/XMLSchema#string